Clarivate and Elsevier expressed support for Ukraine and took measures in response to the Russian military aggression. Companies joined the call of the Ministry of education and science of Ukraine to suspend partnership with the aggressor state, the Russian Federation.
“Clarivate respects and supports the rule of international law and joins the global community in condemning Russia’s attack on Ukraine. Given the continued aggression against Ukraine by Russian forces, Clarivate has made the decision to close its office in Russia effective immediately and we will work to cease commercial activity in Russia in the coming weeks”, the company stated.
Clarivate owns information resources and intellectual property, particularly, Web of Science, a publisher-independent global citation database, patent database Derwent Innovation and other sources.
At the beginning of March, Clarivate suspended all evaluations of new journal submissions from Russia and Belarus in the Web of Science.
Elsevier is one of the biggest world-known publishers of scientific literature that owns a leading platform of peer-reviewed literature ScienceDirect, abstract and citation database of peer-reviewed literature Scopus, and other digital sources. The company had suspended all sales of its products and services in Russia and Belarus since the war started, except for a few health products.
“Elsevier condemns the Russian invasion of Ukraine and joins the call for an immediate cease fire to protect civilians and restore peace. We stand with the people of Ukraine and we are committed to supporting our colleagues and the research and healthcare communities we serve that are impacted by the unfolding humanitarian crisis”, the company states.
Previously Elsevier provided Ukrainian healthcare professionals with free access to such digital platforms as ClinicalKey, Complete Anatomy, and Osmosis.
Clarivate and Elsevier informed that they provide financial support to people affected by the war waged by the Russian Federation.